Sponsored by
This new investigational device uses ultra-low radiofrequency energy to deliver oscillating magnetic fields. It significantly reduced tumor size in mice injected with U87 MG or GL261 glioma cells in their flanks. While still very early in the development process, we hope to see more preclinical research on this device.